How Many Years of Aromatase Inhibitor Tx in Breast Cancer?

There was no disease-free or overall survival benefit with 5 additional years of aromatase inhibitor therapy vs 2 years for women with hormone receptor–positive breast cancers.

from Ob/Gyn & Women’s Health – Medscape http://www.medscape.com/viewarticle/955566
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started